Genmab A/S Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 0.16B0.23B0.55B
Depreciation and Depletion -0.00B-0.01B-0.01B0.02B0.03B0.03B
Share-based Compensation 0.04B0.06B0.07B
Deferred Taxes 20.56B0.01B-0.01B0.24B
Gains from Investment Securities -0.00B-0.01B-0.01B-0.01B-0.01B-0.01B
Asset Writedowns and Impairment -0.18B-0.00B
Cash from Restructuring 0.24B0.08B
Cash from Operations 0.11B0.18B0.90B0.32B0.52B0.71B0.68B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01B-0.01B-0.01B0.01B0.00B0.01B
Depreciation & Amortization (CF) -0.00B-0.01B-0.01B0.02B0.03B0.03B
Change in Working Capital
Change in Inventory -0.01B-0.00B
Change in Accured Expenses 0.14B0.03B0.06B0.08B
Change in Taxes 0.01B-0.05B-0.17B-0.09B-0.16B-0.10B-0.03B
Other Working Capital Changes -0.07B-0.13B0.11B-0.09B-0.19B
Investing Activities
Change in Intangibles -0.04B-0.01B-0.04B-0.03B-0.03B-0.03B-0.02B
Acquisitions 0.00B0.00B0.00B0.00B-1.16B
Cash from Investing Activities -0.20B-0.21B-0.27B-0.11B-0.27B-0.12B-0.00B
Financing Activities
Cash from Financing Activities -0.01B0.38B0.01B-0.05B-0.08B-0.06B-0.00B
Debt Issuance and Repayment
Non-Current Debt 7614.46B
Additional items
Exchange Rate Effect 0.00B0.00B-0.05B0.10B0.06B-0.05B0.10B
Free Cash Flow 0.11B0.18B0.90B0.32B0.52B0.71B0.68B
Net Cash Flow -0.09B0.35B0.64B0.16B0.17B0.54B0.68B